Greg Gerdeman, PhD is a neuroscientist and educator with expertise in the physiological actions of cannabis and the endocannabinoid system. Recently, Greg has gotten involved in the conversation around Delta-8 THC. He comes at the topic from a neuroscientist’s perspective questioning how much we know about how Delta-8 THC affects the body and the brain. He also raises important questions about how the compound is created and what that means for consumer safety and the legality of Delta-8 THC products.
We discuss:

What Delta-8 THC is and how it differs from other THC isomers
Why there is a sudden influx of Delta-8 THC products
How the 2018 Farm Bill opened the door for Delta-8 THC production
The process for creating Delta-8 THC from CBD isolate and the risks associated with it
Whether Delta-8 THC is produced in the plant, and at what levels
What research has been done to understand how Delta-8 THC affects users
and more

Thanks to This Episode’s Sponsor: Project CBD
Project CBD is a California-based nonprofit dedicated to providing up-to-date news and information on the science, movement, and industry around CBD, medical cannabis, and plant-based medicine. Since its founding in 2010, Project CBD has been a trusted resource for patients, medical professionals, scientists, and like-minded advocates.
Learn more about Project CBD at projectcbd.org
Related Links

The Delta-8 THC Controversy
DrGerdeman.com
Greg’s Instagram
Greg’s Facebook
Weir Wellness
Tennessee Farmaceuticals
CannMed Community Board (Facebook Group)
Healthcare Provider Medical Cannabis Research Study

Ver todos los episodios